Patients with idiopathic pulmonary fibrosis in the Yale cohort had higher proportions of CD14+ monocytes (of PBMCs) than healthy controls (p=0·014, figure 2), with percentage of CD14+ cells increasing as mortality risk increased (n=20). This evidence concerns the gene CD14 and idiopathic pulmonary fibrosis.